Obinutuzumab in Connective Tissue Diseases after Former Rituximab-Non-response: a Case Series
Annals of the rheumatic diseases（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined